
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 147254-64-6 | 货号 | BCP14386 |
中文名 | 雷尼司他 | ||
英文名 | Ranirestat | ||
中文别名 | |||
英文别名 | AS-3201; AS3201; AS 3201; SX-3201; SX3201; SX 3201; | ||
SMILES | |||
化学名称 | |||
分子式 | C17H11BrFN3O4 | 分子量 | 420.19 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Ranirestat, also known as AS-3201; SX-3201, is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and PharmaKyorin. It has been granted orphan drug status. The drug is to be used orally. Aldose reductase is an enzyme that catalyzes one of the steps in sorbitol (polyol) pathway which is responsible for formation of fructose from glucose. Aldose reductase activity is increased, parallel to glucose blood levels, in tissues that are not insulin sensitive, including lenses, peripheral nerves and renal glomeruli. Sorbitol does not diffuse through cell membranes easily and therefore accumulates in these tissues, causing osmotic damage, leading to retinopathy and neuropathy. |
相关产品推荐
查看更多 >Tags:Ranirestat 供应商,Ranirestat 购买,Ranirestat 生产,Ranirestat 批量,Ranirestat 供应,Ranirestat 订购,Ranirestat 采购